MedSpaRadar™
Get the Brief

Can a med spa in Kansas offer compounded semaglutide or tirzepatide?

Facility · part of The Practice Perimeter

⛔ THIS IS THE COMPOUNDED-SEMAGLUTIDE QUESTION ANSWERED INSIDE THE DEFINITION ITSELF, AND KANSAS SETS A TEST THE DRUG’S OWN AVAILABILITY DECIDES. Compounding is the combining of components into a compounded preparation "Compounding" means the combining of components into a compounded preparation under either of the following conditions: (A) As the result of a practitioner's prescription drug order or initiative based on the practitioner-patient-pharmacist relationship in the course of professional practice to meet the specialized medical need of an individual patient of the practitioner that cannot be filled by an FDA-approved drug Semaglutide and tirzepatide ARE available as FDA-approved drugs, so in Kansas a compounded version has to answer a specialized medical need of an identified patient that the approved product cannot meet — commercial preference or price is not that need.

K.S.A. § 65-1626(k)(1)(A) (⛔ compounding must meet a need an FDA-APPROVED DRUG CANNOT FILL) · verified Sep 6, 2026 · regulatory monitoring, not legal advice

The rest of what Kansas says on this

Every other rule we have verified under med-spa registration & licensing, each linked to its primary source.

  • The definition's only other limb is not a commercial route. for the purpose of, or incidental to, research, teaching or chemical analysis, and not for sale or dispensing A clinic cannot reach compounded stock through the research limb, because that limb excludes sale and dispensing on its face.

    K.S.A. § 65-1626(k)(1)(B) (the research limb is expressly NOT for sale or dispensing) · verified Sep 6, 2026

  • Kansas does permit stock held ahead of the order, bounded by history rather than by hope. Compounding includes the preparation of drugs or devices in anticipation of receiving prescription drug orders based on routine, regularly observed prescribing patterns. The anticipation must rest on prescribing the practice has actually observed.

    K.S.A. § 65-1626(k)(2) (anticipatory stock is allowed, but only against observed prescribing) · verified Sep 6, 2026

  • And the ordinary act of mixing a supplied vial is outside the definition entirely. Compounding does not include reconstituting any mixed drug according to the FDA-approved labeling for the drug.

    K.S.A. § 65-1626(k)(3) (reconstituting to the FDA label is not compounding at all) · verified Sep 6, 2026

  • A 503B supplier is defined by its federal registration. "Outsourcing facility" means a facility at one geographic location or address that is engaged in the compounding of sterile drugs and has registered with the FDA as an outsourcing facility pursuant to 21 U.S.C. § 353b.

    K.S.A. § 65-1626(vv) (definition of “Outsourcing facility”) · verified Sep 6, 2026

  • No person shall engage in practice of cosmetology, esthetics, nail technology or electrology unless the person holds a valid license, issued by the board, to engage in that practice.

    Kan. Stat. Ann. §65-1902(a)(1) · verified Sep 3, 2026

  • No person shall engage in the practice of tattooing, cosmetic tattooing or body piercing unless the person holds a valid license, issued by the board, to engage in such practice.

    Kan. Stat. Ann. §65-1902(a)(2) · verified Sep 3, 2026

  • Licensed schools may be established and maintained in this state where the profession of cosmetology may be taught or acquired. The license shall be granted by the board upon proper and sufficient showing of competency of the applicant and assurance of compliance by the applicant with the requirements of this act, all reasonable rules and regulations adopted by the board for the proper conduct of the school and all applicable sanitation standards adopted by the secretary of health and environment.

    Kan. Stat. Ann. §65-1903(a)(1) · verified Sep 3, 2026

  • Unless revoked for cause, all licenses of cosmetologists, cosmetology technicians, estheticians, electrologists and manicurists issued or renewed by the board shall expire on the expiration dates established by rules and regulations adopted by the board under this section. Each such license shall be renewable on a biennial basis upon the filing of a renewal application prior to the expiration of the license, payment of the nonrefundable license renewal fee established under this section and the filing of a successfully completed written renewal examination prescribed by the board under this subsection.

    Kan. Stat. Ann. §65-1904(a) · verified Sep 3, 2026

  • KANSAS LISTS THE FAILURE TO REPORT AS ITS OWN GROUND FOR DISCIPLINE, AND THE LIST OF REPORTABLE BODIES IS LONG. It is a ground that “The licensee has failed to report to the board any adverse action taken against the licensee by another state or licensing jurisdiction, a peer review body, a healthcare facility, a professional association or society, a governmental agency, by a law enforcement agency or a court for acts or conduct similar to acts or conduct that would constitute grounds for disciplinary action under this section.”

    Kan. Stat. Ann. § 65-2836(t) · verified Sep 8, 2026

How other states answer this

All 51 states side by side →

Related Kansas questions

Every Kansas question we can answer →

Get Kansas changes as they publish

We scan the Kansas legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address

← All Kansas rules and changes · MedSpaRadar is regulatory monitoring and reference, not legal, medical, or compliance advice. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts. Legislative data via LegiScan (CC BY 4.0).